1. Targeted therapy according to next generation sequencing-based panel sequencing
   Motonobu Saito et al, 2018, FUKUSHIMA JOURNAL OF MEDICAL SCIENCE CrossRef
2. Tumor evolution and chemoresistance in ovarian cancer
   Soochi Kim et al, 2018, npj Precision Oncology CrossRef
3. Absence of PIK3CA mutation in primary mucinous ovarian carcinoma: An analysis of 20 Taiwanese cases by FemtoPath PIK3CA mutation screen kit
   Wan-Ru Chao et al, 2022, Taiwanese Journal of Obstetrics and Gynecology CrossRef
4. Cervical Mesonephric Adenocarcinoma With Novel FGFR2 Mutation
   Stephanie L. Skala et al, 2020, International Journal of Gynecological Pathology CrossRef
5. Identification of novel mutations of ovarian cancer-related genes from RNA-sequencing data for Japanese epithelial ovarian cancer patients
   Saya Nagasawa et al, 2020, Endocrine Journal CrossRef
6. Targeting DNA Damage Response Pathway in Ovarian Clear Cell Carcinoma
   Oscar G. W. Wong et al, 2021, Frontiers in Oncology CrossRef
7. Actionable molecular alterations in advanced gynaecologic malignancies: updated results from the ProfiLER programme
   Romain Varnier et al, 2019, European Journal of Cancer CrossRef
8. Precision Medicine Tumor Boards: Clinical Applicability of Personalized Treatment Concepts in Ovarian Cancer
   Stefanie Aust et al, 2020, Cancers CrossRef
9. Chemotherapy-Induced Distal Enhancers Drive Transcriptional Programs to Maintain the Chemoresistant State in Ovarian Cancer
   Stephen Shang et al, 2019, Cancer Research CrossRef
10. The Hallmarks of Ovarian Cancer: Actionable Genetics, Targetable Pathways, and Predictive Biomarkers
    Khalid El Bairi et al, 2021, Ovarian Cancer Biomarkers CrossRef
11. In silico analysis of DYNLL1 expression in ovarian cancer chemoresistance
    Caglar Berkel et al, 2020, Cell Biology International CrossRef
12. Molecular Landscape in Ovarian Clear Cell Carcinoma
    Nozomu Yanaihara et al, 2021, Molecular Diagnosis and Targeting for Gynecologic Malignancy CrossRef
13. Involvement of ATMIN-DYNLL1-MRN axis in the progression and aggressiveness of serous ovarian cancer
    Caglar Berkel et al, 2021, Biochemical and Biophysical Research Communications CrossRef
14. Landscape of EBV-positive gastric cancer
    Motonobu Saito et al, 2021, Gastric Cancer CrossRef
15. Deleterious Pulmonary Surfactant System Gene Mutations in Lung Adenocarcinomas Associated With Usual Interstitial Pneumonia
    Takayuki Honda et al, 2018, JCO Precision Oncology CrossRef
16. Chromosomal copy number and mutational status are required to authenticate ovarian cancer cell lines as appropriate cell models
    Britta Stordal et al, 2024, Molecular Biology Reports CrossRef
17. Role of RAS signaling in ovarian cancer
    Lubna Therachiyil et al, 2022, F1000Research CrossRef
18. Integrated next-generation sequencing analysis of whole exome and 409 cancer-related genes
    Yuji SHIMODA et al, 2016, Biomedical Research CrossRef
19. Genetic alterations and their therapeutic implications in epithelial ovarian cancer
    Nina Lapke et al, 2021, BMC Cancer CrossRef
20. Target-Sequencing of Female Infertility Pathogenic Gene Panel and a Novel TUBB8 Loss-of-Function Mutation
    Hongxia Yuan et al, 2022, Frontiers in Genetics CrossRef